FFS
TMO icon

Founders Financial Securities’s Thermo Fisher Scientific TMO Stock Holding History

Founders Financial Securities’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
2,159
-132
-6% -$63.4K 0.06% 291
2026
Q1 		$1.15M Sell
2,291
-294
-11% -$160K 0.06% 271
2025
Q4 		$1.5M Buy
2,585
+218
+9% +$123K 0.09% 215
2025
Q3 		$1.15M Buy
2,367
+237
+11% +$110K 0.08% 235
2025
Q2 		$864K Sell
2,130
-144
-6% -$60.2K 0.07% 263
2025
Q1 		$958K Buy
2,274
+37
+2% +$20K 0.08% 228
2024
Q4 		$1.16M Buy
2,237
+112
+5% +$61.6K 0.1% 166
2024
Q3 		$1.31M Buy
2,125
+67
+3% +$39.7K 0.12% 150
2024
Q2 		$1.14M Buy
2,058
+19
+0.9% +$10.9K 0.11% 160
2024
Q1 		$1.19M Buy
2,039
+69
+4% +$38.7K 0.12% 142
2023
Q4 		$1.05M Buy
1,970
+301
+18% +$146K 0.12% 158
2023
Q3 		$845K Buy
1,669
+158
+10% +$84.2K 0.11% 162
2023
Q2 		$788K Buy
1,511
+36
+2% +$19.4K 0.1% 168
2023
Q1 		$850K Sell
1,475
-144
-9% -$81.2K 0.12% 151
2022
Q4 		$892K Buy
1,619
+35
+2% +$18.5K 0.14% 148
2022
Q3 		$803K Buy
1,584
+102
+7% +$57.1K 0.14% 136
2022
Q2 		$805K Sell
1,482
-72
-5% -$39.6K 0.16% 119
2022
Q1 		$918K Sell
1,554
-82
-5% -$47.1K 0.16% 119
2021
Q4 		$1.09M Sell
1,636
-79
-5% -$49.3K 0.2% 102
2021
Q3 		$980K Buy
1,715
+79
+5% +$43.4K 0.2% 104
2021
Q2 		$825K Buy
1,636
+38
+2% +$17.9K 0.16% 129
2021
Q1 		$729K Buy
1,598
+225
+16% +$107K 0.17% 125
2020
Q4 		$640K Buy
1,373
+300
+28% +$141K 0.15% 109
2020
Q3 		$474K Buy
1,073
+84
+8% +$34.7K 0.15% 94
2020
Q2 		$360K Buy
989
+151
+18% +$50.6K 0.12% 121
2020
Q1 		$238K Buy
838
+33
+4% +$10.4K 0.09% 114
2019
Q4 		$262K Buy
805
+60
+8% +$18.2K 0.09% 113
2019
Q3 		$217K Buy
+745
New +$213K 0.07% 123

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Founders Financial Securities's TMO Position: Q2 2026 in Review

Founders Financial Securities reduced its Thermo Fisher Scientific (TMO) stake by 5.8% in Q2 2026, selling an estimated $63.4K and leaving 2,159 shares worth $1.08M. The position accounts for 0.06% of the portfolio, ranked #291.

Founders Financial Securities first reported a position in TMO in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.5M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Founders Financial Securities held 2,159 shares of Thermo Fisher Scientific worth $1.08M as of Q2 2026.
  • Founders Financial Securities sold 132 Thermo Fisher Scientific shares in Q2 2026, an estimated $63.4K.
  • Thermo Fisher Scientific made up 0.06% of Founders Financial Securities's portfolio in Q2 2026, its #291 holding.
  • Founders Financial Securities first reported a position in Thermo Fisher Scientific in Q3 2019 and has held it in 28 quarters since.
  • Founders Financial Securities's Thermo Fisher Scientific position peaked at $1.5M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Founders Financial Securities's 13F filing for Q2 2026, filed 31 Jul 2026.